Your browser doesn't support javascript.
loading
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab.
Rapti, Vassiliki; Moirogiorgou, Evangelia; Koliou, Georgia-Angeliki; Papadopoulou, Kyriaki; Binas, Ioannis; Pentheroudakis, George; Bafaloukos, Dimitrios; Bobos, Mattheos; Chatzopoulos, Kyriakos; Chrisafi, Sofia; Christodoulou, Christos; Nicolaou, Irene; Sotiropoulou, Maria; Magkou, Christina; Koutras, Angelos; Papakostas, Pavlos; Kotsakis, Athanasios; Razis, Evangelia; Psyrri, Amanda; Tryfonopoulos, Dimitrios; Pectasides, Dimitrios; Res, Eleni; Alexopoulos, Athanasios; Kotoula, Vassiliki; Fountzilas, George.
Afiliação
  • Rapti V; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, 11522 Athens, Greece.
  • Moirogiorgou E; Oncology Department, Hygeia Hospital, 15123 Athens, Greece.
  • Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, 11526 Athens, Greece.
  • Papadopoulou K; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.
  • Binas I; Second Department of Medical Oncology, Metropolitan Hospital, 18547 Piraeus, Greece.
  • Pentheroudakis G; Department of Medical Oncology, Medical School, University of Ioannina, 45500 Ioannina, Greece.
  • Bafaloukos D; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), 45500 Ioannina, Greece.
  • Bobos M; First Department of Medical Oncology, Metropolitan Hospital, 18547 Piraeus, Greece.
  • Chatzopoulos K; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.
  • Chrisafi S; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.
  • Christodoulou C; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.
  • Nicolaou I; Second Department of Medical Oncology, Metropolitan Hospital, 18547 Piraeus, Greece.
  • Sotiropoulou M; Department of Histopathology, Agii Anargiri Cancer Hospital, 14564 Athens, Greece.
  • Magkou C; Department of Pathology, Alexandra Hospital, 11528 Athens, Greece.
  • Koutras A; Pathology Department, Evangelismos Hospital, 10676 Athens, Greece.
  • Papakostas P; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, 26504 Patras, Greece.
  • Kotsakis A; Oncology Unit, Hippokration Hospital, 11527 Athens, Greece.
  • Razis E; Department of Medical Oncology, University Hospital of Heraklion School of Medicine, University of Crete, 71500 Crete, Greece.
  • Psyrri A; Third Department of Medical Oncology, Hygeia Hospital, 15123 Athens, Greece.
  • Tryfonopoulos D; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, 12462 Athens, Greece.
  • Pectasides D; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, 11522 Athens, Greece.
  • Res E; Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, 11527 Athens, Greece.
  • Alexopoulos A; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Kifissia 14564 Athens, Greece.
  • Kotoula V; Oncology Department, Hygeia Hospital, 15123 Athens, Greece.
  • Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.
Oncol Lett ; 23(1): 23, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34868360

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article